Hunterbrook’s Production Claims and a Czech Howitzer Dispute Put CSG in the Crosshairs

Defense firm CSG battles credibility crisis from short-seller claims of inflated output and a stalled Czech howitzer contract, with Q1 results due May 20.

The Czechoslovak Group is staring down a synchronised assault on its credibility. A scathing short-seller report alleging inflated ammunition output has collided with a domestic contract snag over Caesar howitzers, leaving the defence firm’s shares trading barely above a 52-week low at €16.42. With the stock down nearly 23% in the past month, all eyes are now on the 20 May release of CSG’s first quarterly results since its January IPO.

Hunterbrook Media fired the opening salvo earlier this month, claiming the group merely refurbishes old munitions rather than producing new rounds. The short-seller estimates CSG’s real capacity at just 280,000 artillery shells per year, a far cry from the 630,000 the company itself cites. Management has forcefully rejected the allegations, pointing to the due diligence conducted by banks ahead of the flotation, and is considering legal action. Concrete production figures in the upcoming earnings report will be the first opportunity to put hard data behind the rhetoric.

At the same time, CSG’s domestic reputation has taken a hit from a very different kind of friction. A 10.3 billion Czech crown contract to deliver 62 Caesar howitzers to the Czech army has stalled. The first four units were due to enter troop trials in April, but a dispute between prime contractor KNDS and the defence ministry – which has demanded fixes for specific defects – has frozen acceptance. Work at CSG subsidiary Excalibur Army, which supplies local components, continues, but the delay risks denting confidence in the group’s home-market reliability. The company did, however, offer a positive distraction on the export front by unveiling the CFL-120 Karpat medium tank at a Bratislava arms fair, a 30-tonne vehicle built with a Turkish FNSS chassis and Italian Leonardo turret, targeting Slovakia’s upcoming order for up to 108 new tanks.

Investor nerves are already baked into the stock’s extraordinary volatility – an annualised 73% – and the market has yet to fully price in other ticking clocks. A Slovak framework contract for ammunition, backed by cheap EU loans, requires a second member state to sign on by the end of this month. No partner has yet committed, and without one the group faces higher financing costs. Yet there are also countervailing signals: Moody’s recently lifted CSG’s rating to investment grade, which lowers future interest expenses and opens the door to tightly regulated institutional investors. The company continues to pursue expansion, including a planned 49% stake in Austria’s Hirtenberger Defence Systems and a joint venture in Azerbaijan to upgrade armoured vehicles.

All nine analysts covering the stock rate it a buy, with a consensus price target of €35.40 and JPMorgan as high as €40. That optimism rests squarely on the numbers due out next week. To silence the short-sellers and reassure the market that the Slovak subsidy deadline can be met, CSG needs to deliver a clean set of operating margins and cash-flow data. The earnings call on 20 May will either validate the bull case or deepen the selloff.